EXPAND trial of Erbitux in advanced gastric cancer does not meet primary endpoint
Erbitux in combination with cisplatin and capecitabine does not significantly increase progression-free survival in patients with…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Provepharm signs three new distribution agreements in Europe
Agreement will cover eight additional European countries
Lupin receives FDA approval for generic Ortho Tri-cyclen Lo tablets
Lupin's subsidiary, Lupin Pharmaceuticals has received approval for its Norgestimate and Ethinyl Estradiol tablets, 0.18 mg/0.025…
Serum Institute of India acquires Bilthoven Biologicals
Serum Institute will get access to technology and expertise for making injectable polio vaccine Serum Institute of India, the…
GSBTM to award biotech entrepreneurs
Biotechnopreneur Programme Awards will be followed by DBT sponsored workshops at Ahmedabad Gujarat will award some of the best…
Ecobliss India bags three awards for packaging
It has won the awards for new packaging products like LED lamps, agriculture seeds and innovative lighting Ecobliss India's all…
Frank Pieters joins Cipla
He has been appointed as Head of European Region and Global Respiratory Business Cipla has appointed Frank Pieters as the Head of…
Brazil takes control over its pharma market: GBI Research
But generics threaten to cut future profits Continuous support from the government is helping the Brazilian pharmaceutical market…
Astrazeneca and Cellworks collaborate to find new treatment for tuberculosis
It will pave the way for the creation of platforms and approaches to handle Multi Drug Resistant Tuberculosis AstraZeneca and…
Dr Reddy’s launches Ibandronate Sodium tablets
Dr Reddy’s Laboratories has launched Ibandronate Sodium tablets (150 mg), a bioequivalent generic version of BONIVA tablets in the…
Argentina clinical research market tempts CROs, MNC pharma : GBI Research
The country is an attractive market for CROs due to its good clinical infrastructure, cost compliance, large population A new…
Dürr and Caloric sign environmental systems agreement
Will collaborate in the field of incinerators for disposal of saline exhaust gases and residual liquids
Ferrer Internacional withdraws marketing authorisation application for Egrifta
Egrifta was intended to be used for the treatment of excess visceral adipose tissue
Cancer costs call for clever use of capital: GBI Research
Higher levels of performance are now demanded from oncology treatments in terms of survival and remission
Selvita, Orion Pharma achieve research milestone in Alzheimer’s disease programme
Molecules from two different chemical families will progress into further pre-clinical characterisation
Imminent patent expiry of key blockbusterdDrugs to benefit generics manufacturers: Frost &…
The balance in terms of healthcare expenditure and sales revenue is poised to shift from developed to emerging markets
Mylan confirms first-to-file patent challenge relating to Pristique tablets
Pfizer, Wyeth, Wyeth Pharmaceuticals, and PF Prism CV sues Mylan
Pfizer appoints Aijaz Tobaccowalla as Managing Director, India
Previously from Wyeth, Tobaccowalla now leads Business Technology for all Pfizer's biopharma business units
New second-line drug for type II diabetes results in less hypoglycaemia: The Lancet
The group treated with linagliptin also experienced fewer cardiovascular events